Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Clascoterone 1% cream is a promising new treatment for acne.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

A man developed skin issues from cancer medication, which improved with specific treatments.

Tofacitinib may help regrow hair in alopecia areata patients.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Topical tofacitinib is effective and safe for treating alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.